OREX Related Analyst Comments

Feb 4, 2013 10:45 AM VIVUS, Inc. (VVUS) Qsymia Prescriptions Show Gains During Slow Holiday Week (ARNA) (OREX)

Dec 21, 2012 11:56 AM JPMorgan Confident Orexigen's (OREX) Will Receive FDA Approval; Comments on Meeting

Dec 18, 2012 03:23 PM Orexigen (OREX) Slumps as Many Expected 'Better News' for Contrave

Dec 10, 2012 09:10 AM VIVUS (VVUS) Qsymia Prescriptions Pop Following Thanksgiving Glut (ARNA) (OREX)

Oct 31, 2012 02:18 PM Latest Qsymia Data Shapes Up Potential Bear Case for VIVUS (VVUS) and Peers (ARNA) (OREX)

Oct 23, 2012 07:42 AM Jefferies Boosts Target on Orexigen (OREX) as FDA Gets Close to Admitting Error

Oct 22, 2012 10:08 AM VIVUS (VVUS) Qsymia Prescriptions Keep Chugging, Gain 27%+ Last Week

Oct 8, 2012 12:48 PM VIVUS' (VVUS) Qsymia Prescription Insurer Pay Rate Rose 5% in Week Two

Sep 21, 2012 12:19 PM Not Expecting E.U. Approval for Vivus' (VVUS) Qsiva, Could be a Plus for Orexigen (OREX) - Analyst

Sep 6, 2012 03:42 PM Orexigen (OREX) Surges On 'Aggressive' Buy Calls Ahead of Catalysts

Jul 18, 2012 08:51 AM VIVUS's (VVUS) Qsymia Approval a Clear Positive for Orexigen (OREX) - Leerink

Jul 16, 2012 11:09 AM VIVUS (VVUS) Gets a Boost from Uber-Bullish Orexigen (OREX) Call

Jul 13, 2012 08:43 AM With Plenty of Good Arguments for Both Bulls and Bears, VIVUS (VVUS) Qnexa Approval at 50/50 - Jefferies

Jun 28, 2012 10:21 AM Canaccord Genuity Morning Coffee on Arena Pharma. (ARNA): Does This Mean I Can Keep Eating Super-Sized Double Big Mac Meals?

Mar 26, 2012 10:54 AM Leerink Swann Says Orexigen (OREX) is Still the Best Play After Obesity Drug CV Study Briefing Documents, Boosts Target (VVUS)

Feb 23, 2012 11:20 AM Leerink Swann: Buyers of Orexigen Therapeutics (OREX) Into Next Panel; Preferred Small/Midcap Biotech Pick

Sep 23, 2011 12:51 PM Jefferies Raises Price Target on Orexigen Therapeutics (OREX) as Contrave is Back Up & Running

Sep 22, 2011 04:46 PM Needham & Company Maintains a 'Buy' on Vivus (VVUS); Risks Around Topiramate/Phentermine are Manageable

Sep 21, 2011 08:56 AM Brean Murray Carret & Co. Maintains a 'Sell' on Vivus; Orexigen (OREX) News Not Immediately Relevant to VVUS

Feb 2, 2011 10:41 AM Canaccord Genuity Morning Coffee on Orexigen (OREX): Not Worth The Weight

Feb 1, 2011 12:51 PM Cowen Sees Orexigen (OREX) Raising $200M in Capital to Finish Contrave Study

Jan 31, 2011 02:14 PM Orexigen (OREX) Shares Surge Ahead of FDA Response for Contrave NDA

Jan 31, 2011 09:27 AM Canaccord Genuity maintains a 'Buy' on Orexigen Therapeutics (OREX); PDUFA Expected Today

Dec 14, 2010 09:13 AM Canaccord Genuity on Life Sciences/Biotechnology: BEST IDEAS FOR 2011: AMRN, DNDN, FOLD, NPSP, OREX, VRUS

Dec 9, 2010 10:56 AM Canaccord Genuity Reiterates a 'Buy' on Orexigen Therapeutics (OREX); Provides More Clarity on Contrave's Path Forward; Stock Has Room

Dec 8, 2010 10:46 AM Canaccord Genuity Reiterates a 'Buy' on Orexigen Therapeutics (OREX); OREX Shoots and Scores; FDA Panel Gives Contrave a Big Fat Yes

Dec 8, 2010 09:19 AM Jefferies Raises Price Target on Orexigen Therapeutics (OREX), Maintains Buy Rating

Dec 8, 2010 07:50 AM Needham & Company Reiterates a 'Buy' on Vivus (VVUS); Contrave FDA Advisory Committee Vote a Positive for Obesity Space, Qnexa, and Vivus

Dec 6, 2010 11:04 AM Canaccord Genuity Morning Coffee on Orexigen (OREX): Weighing in...

Nov 30, 2010 10:52 AM Canaccord Genuity Reiterates a 'Buy/Top Pick' Rating on Orexigen Therapeutics (OREX); Buy Before 12/7 Ad Com

Sep 24, 2010 12:46 PM FDA Decision On Avandia Is A Positive For VIVUS (VVUS) and Orexigen (OREX) - Analyst

Sep 16, 2010 10:51 AM Canaccord Genuity on Life Sciences/Biotechnology: Takeaways from the Sibutramine Panel

Sep 29, 2008 11:13 AM Canaccord Adds Orexigen Therapeutics (OREX) to Best Ideas List; $21 PT